The GYS1 gene helps muscle cells, including heart muscle, store sugar in the form of glycogen so it can be used later for energy. This gene helps your body keep a reserve fuel supply for movement and steady heart function. If the gene does not work properly, muscles may run short of stored energy, which can lead to exercise intolerance, cramps, or tiredness. Some people with harmful variants in the GYS1 gene can also develop heart rhythm problems or changes in the heart muscle.
What is a gene?
Genes are stretches of DNA that carry instructions cells use to make molecules or regulate activities in the body. Some provide the code for proteins, which do much of the cell’s work. Others mainly direct when certain activities happen, where they take place, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
GYS1Gene function
What if the gene works
The GYS1 gene helps muscle cells store sugar as glycogen. This gives muscles a ready energy reserve for exercise and supports normal heart muscle function.
Risk
What if the gene does not work
When the GYS1 gene does not work well, muscles cannot store glycogen normally. Depending on whether variants are milder or more severe, people may have exercise intolerance and muscle cramps, or early heart involvement such as cardiomyopathy or rhythm problems.
Treatment
What does that mean for your treatment
For people with a pathogenic variant in the GYS1 gene, no GYS1-specific treatment or drug choice guideline is currently established. The GYS1 gene is being studied as a drug target in conditions with harmful glycogen buildup, where lowering GYS1 activity might help limit storage.
Conditions associated with GYS1
Gene function
What if the gene works
Your muscles need a ready backup fuel supply for walking, climbing stairs, and exercise. The GYS1 gene helps cells build glycogen, the stored form of sugar. This lets muscle and heart cells save glucose for later energy use.
The GYS1 gene gives cells instructions for a protein that builds glycogen, the stored form of sugar. In simple terms, this is how the GYS1 gene stores sugar in muscle and heart cells for later use.
When glucose is available after eating, this gene helps cells set some of it aside instead of using it all at once. That stored glycogen acts like a compact backup fuel supply between meals and during activity.
In skeletal muscle, glycogen made with help from the GYS1 gene supports quick access to energy during movement. This helps with everyday tasks like walking up stairs or starting exercise.
The same glycogen making process also works in heart muscle, where a small stored fuel supply helps meet ongoing energy needs. By doing so, the GYS1 gene supports routine cell activity in a tissue that works nonstop.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GYS1 gene can reduce or block muscle glycogen synthase, so cells make less glycogen. Some changes weaken the protein or lower its activity, while more severe variants stop it from being made or working at all. This range helps explain how GYS1 gene variants affect glycogen synthase activity and why some people have milder, later-onset muscle glycogen storage disease, while others develop earlier, more noticeable symptoms.
How variants are linked to conditions
Pathogenic variants in the GYS1 gene can cause muscle glycogen storage disease type 0, a rare inherited condition that may lead to exercise intolerance, muscle cramps, and unusual fatigue during activity. In some families, GYS1 gene variants linked to conditions also include heart involvement, especially cardiomyopathy and heart rhythm problems. These diagnosis-causing variants are usually inherited from both parents, while most other GYS1 variants found on testing do not by themselves predict disease.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely present in the general population. Most do not have a direct effect on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For GYS1, risk is mainly shaped by inheritance: it is higher when a child inherits harmful changes in both copies of the gene, so family history can matter. There is not enough evidence to say that lifestyle or environmental factors clearly increase or lower the chance of a GYS1-related condition.
Inheritance of GYS1 variants
Variants in the GYS1 gene linked to GYS1-related glycogen storage disease are inherited in an autosomal recessive pattern. This means a person usually inherits one changed copy of the GYS1 gene from each parent. Parents who each carry one variant are typically unaffected, but with each pregnancy they have a 25% chance of having a child with the condition, a 50% chance of having a child who is a carrier, and a 25% chance of having a child without either familial variant. In practical terms, how GYS1 gene variants are inherited usually involves both sides of the family contributing one altered copy.
What does my GYS1 result mean for my family?
For families with a disease-causing GYS1 result linked to the recognized muscle glycogen storage condition, the pattern is usually recessive, which means close relatives may be healthy carriers without knowing it. Brothers and sisters could also have the condition or be carriers, and other relatives may wish to learn whether the variant runs in the family. The exact family impact depends on whether someone has one changed copy or two.
Genetic information
Genetic testing
How you find out about variants
GYS1 genetic testing looks for variants in the GYS1 gene using a blood sample, saliva, or cheek swab. A lab reads the gene's DNA code to check for changes linked to glycogen storage disease type 0 or polyglucosan body myopathy, depending on the test. Results may show a disease-causing variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
You may want to consider GYS1 genetic testing if there is a known GYS1 change in your family, or if someone has unexplained exercise intolerance, painful muscle cramps, or heart muscle problems that suggest a rare problem with how muscles store fuel. Testing can help confirm whether GYS1 is the cause and clarify family risk.
A genetic result is only one part of your health story
A genetic result can be informative, but what it reveals depends on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug faster or slower than expected, while others may be more or less sensitive to its effects. This helps explain why the same treatment works well for one person but not as well for another. These differences are common and can influence both benefit and the chance of side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect a person’s response to medications. By studying links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how the body processes a drug and how strong its effects are. This information can support more informed and personalized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the GYS1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about medicines, side effects, or how well a treatment is working are best discussed with your doctor.
History
Researchers first studied glycogen synthase as an enzyme in muscle long before the GYS1 gene itself was identified. In the late 20th century, scientists separated the muscle form from the liver form, which helped show that different genes control similar steps in glycogen storage. From these first observations, research expanded steadily. By the 1990s, the GYS1 gene had been mapped and cloned, allowing inherited changes to be linked to rare glycogen storage conditions. Later reports connected pathogenic GYS1 variants with muscle glycogen storage disease and, in some families, heart muscle disease. These findings turned earlier biochemical clues into a clearer genetic picture and shaped how clinicians recognize GYS1 related conditions today.